PTC Therapeutics (NASDAQ:NASDAQ:PTCT) Q2 2022 Earnings Conference Call August 4, 2022 16:30 ET Company Participants Kylie O'Keefe - Senior Vice President, Head of Global Commercial &.
Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Rating) have earned an average recommendation of “Hold” from the nine analysts that are currently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell rating, five have given a hold rating and three have issued a buy rating on the company. […]
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Rating) has been given a consensus recommendation of “Hold” by the nine research firms that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and three have issued a buy rating on the company. […]